Cancer Biology & Medicine

►►Submit your paper by clicking the ABOVE RED TAG "ONLINE SUBMISSION".

 

►►Very important notification on publication fee

Effective February 2019, Cancer Biology & Medicine, as an open access journal, will charge a reasonable publication fee of $1,500/¥10,000 for each accepted article (all article types). No fees will be charged for invited articles.


Cancer Biology & Medicine

Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:

● Cancer genetics

● Cancer and stem cell biology

● Molecular and clinical immunology

● Cancer prevention and epidemiology

● Cancer biomarkers

● Radiation oncology

● Oncology clinical trials

● Mechanisms of drug sensitivity and resistance

● Targeted therapy and immunotherapy

● Multidisciplinary treatment and personalized medicine

Author Benefits

● Easy submission via online system

● Efficient and professional peer review

● Rapid pre-print online publication

● No charge for publication and open access

● International visibility-All full texts are free in PubMed Central

 

Announcements

 

Breakthrough Summit

 

2019 Breakthrough Summit will be held on October 11-13, 2019 in Bangkok, Thailand.

Click here to visit its official website.

 
Posted: 2019-05-22
 

Publication of the 2nd issue in 2019

 

In the 2nd issue of Cancer Biology & Medicine, an invited editorial by Prof. Xiubao Ren comments the breakthrough research on immune suppressor Siglec-15 and presents his deep perspective and insights. Supported by a large population-based study, Prof. Martha L. Slattery et al. composed a review which discusses the functional role of miRNAs and colorectal cancer. Clinical studies in this issue involve the role of telmisartan in melanoma, effects of palbociclib in treatment of oral squamous cell carcinoma, and survival outcomes of NSCLC patients initiated on afatinib, etc. Meanwhile, some featured basic researches, such as HBx in hepatocarcinogenesis, are also included.

 

We hope all of these articles will greatly benefit your research and clinical practice. Thank you for your attention and welcome to submit your work to Cancer Biology & Medicine.
 
Posted: 2019-05-14
 
More Announcements...

Vol 16, No 2: May 2019

Table of Contents

Editorial

Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle PDF HTML
Xiubao Ren 205-210

Review

The functional role of miRNAs and colorectal cancer: insights from a large population-based study PDF HTML
Lila E. Mullany, Martha L. Slattery 211-219

Original Article

Dorsomorphin induces cancer cell apoptosis and sensitizes cancer cells to HSP90 and proteasome inhibitors by reducing nuclear heat shock factor 1 levels PDF HTML
Na Li, Ting Wang, Zongmeng Li, et al. 220-233
Identification of anticancer drugs to radiosensitise BRAFwild- type and mutant colorectal cancer PDF HTML
Rebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, et al. 234-246
Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics PDF HTML
Jelena Grahovac, Tatjana Srdić-Rajić, Juan Francisco Santibañez, et al. 247-263
Effects of palbociclib in oral squamous cell carcinoma and the role of PIK3CA in conferring resistance PDF HTML
Nur Syafinaz Zainal, Bernard Kok Bang Lee, Zheng Wei Wong, et al. 264-275
Hepatitis B virus X protein enhances hepatocarcinogenesis by depressing the targeting of NUSAP1 mRNA by miR-18b PDF HTML
Zhe Yang, Jiong Li, Guoxing Feng, et al. 276-287
Attenuated plasmodium sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice PDF HTML
Dong Zhou, Hong Zheng, Quanxing Liu, et al. 288-298
Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer PDF HTML
Huizhi Sun, Nan Yao, Siqi Cheng, et al. 299-311
Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy PDF HTML
Jing Si, Benlong Yang, Rong Guo, et al. 312-318
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers PDF HTML
Andreas M. Luebke, Ali Attarchi-Tehrani, Jan Meiners, et al. 319-330
LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival PDF HTML
Yi Que, Zhixin Fang, Yuanxiang Guan, et al. 331-340
Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data PDF HTML
Ashley M. Hopkins, Adel Shahnam, Sasha Zhang, et al. 341-349
Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients PDF HTML
Yuhan Zhang, Shuaibing Wang, Beibei Yang, et al. 350-360
Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies PDF HTML
Jie Tian, Guanchu Liu, Chunjian Zuo, et al. 361-376
Cytosolic phospholipase A2α modulates cell-matrix adhesion via the FAK/paxillin pathway in hepatocellular carcinoma PDF HTML
Piao Guo, Yuchao He, Lu Chen, et al. 377-390


OUR FRIENDS